Literature DB >> 27469183

Endocrine Disorders in Cystic Fibrosis.

Scott M Blackman1, Vin Tangpricha2.   

Abstract

Cystic fibrosis is frequently complicated by endocrine disorders. Diabetes can be expected to affect most with CF and pancreatic insufficiency and varies widely in age of onset, but early identification and treatment improve morbidity and mortality. Short stature can be exacerbated by relative delay of puberty and by use of inhaled corticosteroids. Bone disease in CF causes fragility fractures and should be assessed by monitoring bone mineral density and optimizing vitamin D status. Detecting and managing endocrine complications in CF can reduce morbidity and mortality in CF. These complications can be expected to become more common as the CF population ages.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Hypoglycemia; Hypogonadism; Osteoporosis; Short stature

Mesh:

Year:  2016        PMID: 27469183      PMCID: PMC5354098          DOI: 10.1016/j.pcl.2016.04.009

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  63 in total

1.  Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium.

Authors:  Laura S Hillman; James T Cassidy; Mihaela F Popescu; John E Hewett; Joseph Kyger; J David Robertson
Journal:  Pediatr Pulmonol       Date:  2008-08

2.  ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents.

Authors:  Antoinette Moran; Kubendran Pillay; Dorothy J Becker; Carlo L Acerini
Journal:  Pediatr Diabetes       Date:  2014-09       Impact factor: 4.866

Review 3.  Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Authors:  J Jacquot; M Delion; S Gangloff; J Braux; F Velard
Journal:  Osteoporos Int       Date:  2015-10-02       Impact factor: 4.507

4.  An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation.

Authors:  V Tangpricha; A Kelly; A Stephenson; K Maguiness; J Enders; K A Robinson; B C Marshall; D Borowitz
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

Review 5.  Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions.

Authors:  S C Wong; R Dobie; M A Altowati; G A Werther; C Farquharson; S F Ahmed
Journal:  Endocr Rev       Date:  2015-12-31       Impact factor: 19.871

6.  The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.

Authors:  Paulus Ripa; Ian Robertson; David Cowley; Margaret Harris; I Brent Masters; Andrew M Cotterill
Journal:  Clin Endocrinol (Oxf)       Date:  2002-03       Impact factor: 3.478

7.  Correlation between genotype and phenotype in patients with cystic fibrosis.

Authors: 
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

8.  Severe bone demineralisation is associated with higher mortality in children with cystic fibrosis.

Authors:  R O'Reilly; P Fitzpatrick; G Leen; B Elnazir; P Greally
Journal:  Ir Med J       Date:  2009-02

9.  Evaluation of teriparatide for treatment of osteoporosis in four patients with cystic fibrosis: a case series.

Authors:  Oranan Siwamogsatham; Kelly Stephens; Vin Tangpricha
Journal:  Case Rep Endocrinol       Date:  2014-03-06

10.  Genetic modifiers of cystic fibrosis-related diabetes.

Authors:  Scott M Blackman; Clayton W Commander; Christopher Watson; Kristin M Arcara; Lisa J Strug; Jaclyn R Stonebraker; Fred A Wright; Johanna M Rommens; Lei Sun; Rhonda G Pace; Sarah A Norris; Peter R Durie; Mitchell L Drumm; Michael R Knowles; Garry R Cutting
Journal:  Diabetes       Date:  2013-05-13       Impact factor: 9.461

View more
  18 in total

1.  GH-IGF-1 Axis in Children with Cystic Fibrosis.

Authors:  Sara Pagani; Elena Bozzola; Gloria Acquafredda; Vito Terlizzi; Valeria Raia; Fabio Majo; Alberto Villani; Mauro Bozzola
Journal:  Clin Med Res       Date:  2019-08-28

2.  Deregulation of the growth hormone/insulin-like growth factor-1 axis in adults with cystic fibrosis.

Authors:  C Pascucci; R V De Biase; D Savi; S Quattrucci; A M Isidori; C Lubrano; L Gnessi; A Lenzi
Journal:  J Endocrinol Invest       Date:  2017-11-02       Impact factor: 4.256

3.  Impact of CFTR-modulating drugs on GH-IGF-1 axis impairment in adult patients with cystic fibrosis.

Authors:  C Pascucci; R V De Biase; D Savi; S Quattrucci; L Gnessi; C Lubrano; A Lenzi
Journal:  J Endocrinol Invest       Date:  2019-04-20       Impact factor: 4.256

Review 4.  [Cystic fibrosis being a polyendocrine disease (Review)].

Authors:  N B Chagay; G Ya Khayt; T M Vdovina; A A Shaforost
Journal:  Probl Endokrinol (Mosk)       Date:  2021-03-30

Review 5.  Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis.

Authors:  Natalie E West; Traci M Kazmerski; Jennifer L Taylor-Cousar; Vin Tangpricha; Kelsie Pearson; Moira L Aitken; Raksha Jain
Journal:  Pediatr Pulmonol       Date:  2021-10-08

6.  Experiments suggesting extra-digestive effects of enteral pancreatic amylase and its peptides on glucose homeostasis in a pig model.

Authors:  Stefan G Pierzynowski; Kateryna Goncharova; Peter C Gregory; Björn Weström; Sergiy E Podpryatov; Sergii S Podpriatov; Jarosław Woliński; Hlib Repich; Nils Wierup; Liudmyla Lozinska
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

7.  Automatic referrals within a cystic fibrosis multidisciplinary clinic improve patient evaluation and management.

Authors:  Amy Darukhanavala; Ted Kremer
Journal:  J Clin Transl Endocrinol       Date:  2021-06-12

Review 8.  Gender differences in bronchiectasis: a real issue?

Authors:  Celine Vidaillac; Valerie F L Yong; Tavleen K Jaggi; Min-Min Soh; Sanjay H Chotirmall
Journal:  Breathe (Sheff)       Date:  2018-06

9.  Effect of backpack carrying on forced vital capacity in cystic fibrosis: A randomized crossover-controlled trial.

Authors:  Yann Combret; Clement Medrinal; Guillaume Prieur; Aurora Robledo Quesada; Pascal Le Roux; Grégory Reychler
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

Review 10.  Inflammatory Diseases and Growth: Effects on the GH-IGF Axis and on Growth Plate.

Authors:  Francesca Cirillo; Pietro Lazzeroni; Chiara Sartori; Maria Elisabeth Street
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.